子宫内膜容受性的免疫决定因素:生物学视角
本文从生物学视角综述免疫细胞在子宫内膜容受性中的作用,指出免疫细胞通过组织重塑和免疫调节促进胚胎植入,并对复发性植入失败和复发性流产中子宫免疫细胞数量或功能改变进行讨论,认为现有诊断工具过于简单、临床效用有限,安全有效的干预措施尚处于早期阶段。
要点
- 免疫细胞通过组织重塑和免疫调节促进上皮附着能力、调控蜕膜细胞分化并重塑子宫血管。
- 复发性植入失败和复发性流产女性可能存在子宫自然杀伤细胞和调节性T细胞数量或功能改变。
- 当前诊断测试过于简单且临床效用有限,安全有效的免疫调节干预尚处于早期阶段。
核心结论
- 免疫细胞是子宫内膜容受性和早期胎盘发育所必需,从生物学角度发挥质量控制作用,条件有利时促进植入成功,生理条件不理想时限制容受性。
研究设计与样本
- 原文未报告研究设计。
主要发现
- 免疫细胞发挥组织重塑和免疫调节作用,促进上皮附着能力、调控蜕膜细胞分化、重塑子宫血管、控制和消退炎症激活并抑制对父源性同种抗原的破坏性免疫。
- 复发性植入失败和复发性流产女性可能表现出某些子宫免疫细胞群数量和功能改变,最显著的是子宫自然杀伤细胞和调节性T细胞。
- 临床前和动物研究表明这些细胞的缺陷或异常激活状态可能是不孕病理生理机制的因果因素。
关键数值与推荐
- 原文未报告关键数值或推荐条款。
临床怎么用
- 免疫细胞是诊断评估和治疗干预的靶点,但当前诊断测试过于简单且临床效用有限,需要反映子宫免疫细胞表型和网络的全复杂性和扰动范围。
- 安全有效的免疫细胞调节干预尚处于早期阶段,需要与特定诊断标准匹配的个性化方法。
局限性
- 当前诊断测试过于简单且临床效用有限。
- 安全有效的干预措施尚处于早期阶段。
- 需要解决知识空白才能完全实现靶向子宫免疫反应疗法的前景。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Immune cells are essential for endometrial receptivity to embryo implantation and early placental development. They exert tissue-remodeling and immune regulatory roles-acting to promote epithelial attachment competence, regulate the differentiation of decidual cells, remodel the uterine vasculature, control and resolve inflammatory activation, and suppress destructive immunity to paternally inherited alloantigens. From a biological perspective, the endometrial immune response exerts a form of "quality control"-it promotes implantation success when conditions are favorable but constrains receptivity when physiological circumstances are not ideal. Women with recurrent implantation failure and recurrent miscarriage may exhibit altered numbers or disturbed function of certain uterine immune cell populations-most notably uterine natural killer cells and regulatory T cells. Preclinical and animal studies indicate that deficiencies or aberrant activation states in these cells can be causal in the pathophysiological mechanisms of infertility. Immune cells are, therefore, targets for diagnostic evaluation and therapeutic intervention. However, current diagnostic tests are overly simplistic and have limited clinical utility. To be more informative, they need to account for the full complexity and reflect the range of perturbations that can occur in uterine immune cell phenotypes and networks. Moreover, safe and effective interventions to modulate these cells are in their infancy, and personalized approaches matched to specific diagnostic criteria will be needed. Here we summarize current biological understanding and identify knowledge gaps to be resolved before the promise of therapies to target the uterine immune response can be fully realized.
引用
- Robertson SA, Moldenhauer LM, Green ES, et al. Immune determinants of endometrial receptivity: a biological perspective. Fertil Steril. 2022. PMID: 35618356. doi:10.1016/j.fertnstert.2022.04.023
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。